Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAR-901 booster vaccine for TB prevention in adolescents
NCT02712424Phase 2Completed
- Sponsor
- Dartmouth Health
- Start
- Mar 2016
- Primary completion
- Feb 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of DAR-901 in Tuberculosis (TB), sponsored by Dartmouth Health. Started Mar 2016; status: completed.
02
Drugs
DAR-901
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02712424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712424.